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Letter to the EditorThe AMPK-Malonyl-CoA-CPT1 Axis
in the Control of Hypothalamic
Neuronal FunctionDear Editor,
We would like to offer alternative per-
spectives to those suggested in a recent
article in Cell Metabolism on the potential
roles of FAS, malonyl-CoA and CPT1 in
hypothalamic function. In Lopez et al.
(2008) the fasting- and ghrelin-mediated
(AMPK-dependent) downregulation of
FAS expression was proposed to be ‘‘an
adaptive mechanism that helps to prevent
malonyl-CoA from decreasing to deleteri-
ously low levels in the hypothalamus.’’ We
suggest that the downregulation of FAS
serves to prime neurons to respond to re-
feeding by enabling a more rapid increase
in [malonyl-CoA] when feeding signals
reach the hypothalamus; this would
control meal size more efficiently. The ra-
tionale for a CPT1C-associated signaling
role for malonyl-CoA independently from
its inhibition of CPT1 activity is not sup-
ported by existing data. CPT1C (the activ-
ity of which is difficult to detect in vitro
even with the use of sensitive radiochem-
ical assays, owing to its extremely low
catalytic constant [Sierra et al., 2008])
binds malonyl-CoA with the same affinity
as CPT1A (Price et al., 2002). We have
suggested that it could buffer the avail-
ability of malonyl-CoA in specific micro-
environments within the cell (Price et al.,
2002). Malonyl-CoA is capable of signal-
ing indirectly through its inhibition of the
highly active isoforms CPT 1A and/or
1B; such inhibition raises the concentra-
tions of cytosolic long-chain acyl-CoA
(LC-CoA) esters, potentially making CPT 1
activity central to neuroendocrine cell
responses, as these metabolites are (1)
activators of the K+ATP channels and
therefore able to affect neuronal electrical
activity, and (2) sensitizers of vesicular
(neuro)peptide secretion.In (Lopez et al., 2008) correlations were
drawn between short-term changes in
CPT activity measured in vitro, and tissue
malonyl-CoA content measured in the
VMH. However, during assay of CPT activ-
ity, the malonyl-CoA would have been infi-
nitely diluted in tissue extracts and assay
media. However, mechanisms that specif-
ically enable CPT1A (not 1C) to adapt its
sensitivity to malonyl-CoA inhibition to
different physiological conditions, coinci-
dent with changes in cellular [malonyl-
CoA], do exist and amplify the effects of
changes in the concentration of the inhib-
itor in vivo; see Zammit (1999) for review.
More generally, these mechanisms are
also likely to be important in adapting the
function of CPT1A-expressing hypotha-
lamic neurons to factors such as dietary
fat composition, obesity, and fasting, as
they do in other cell types in which
CPT1A is expressed. Similarly, the modu-
lation of CPT1A sensitivity to malonyl-CoA
through altered mitochondrial outer mem-
brane composition (Zammit, 1999) has the
potential to be involved in the reported at-
tenuation of the CPT1A-mediated anorex-
igenic signal in rats maintained for 3 days
on a high-fat diet (Pocai et al., 2006).
The high CPT activity measured in the
VMH by Lopez et al. (2008) using a colori-
metric assay was correlated with the im-
munoquantification of only one (CPT1C)
of the three isoforms of CPT1 that are ex-
pressed in the hypothalamus (Price et al.,
2002). Owing to the very low intrinsic cat-
alytic activity of CPT1C, it is highly likely
that the activity measured was due to
CPT1A and/or CPT1B, whereas immuno-
quantification was specifically of CPT1C
protein. This discrepancy may require
a re-evaluation of some of the data pre-
sented. The absence of an effect of icvCell Metabolism 8, Setomoxir alone on food intake in Lopez
et al. (2008) differs from previous observa-
tions (Pocai et al., 2006), namely that icv-
delivered pharmacological and antisense
oligomer-mediated specific inhibition of
hypothalamic CPT1A results in a rapid
inhibition of food intake and hepatic glu-
cose production. This discrepancy sug-
gests that the exact site of icv delivery
may determine the an/orexigenic re-
sponse, depending on which precise cell
types are affected and on which CPT1
isoform(s) are expressed therein. It is
also possible that opposite directions of
changes in CPT 1 activity, and thus of
[acyl-CoA], are required for activation/
inhibition of the electrical activity of par-
ticular types of neurons. We hope that a
thorough appreciation of the metabolic
principles involved in the regulation of
the AMPK-malonyl-CoA-CPT 1 axis may
improve our understanding of hypotha-
lamic neuronal function in response and
adaptation to dietary signals.
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